Europe Biomaterials Market

The report "Europe Biomaterials Market by Type (Metallic [Gold, Magnesium], Ceramic [Aluminum Oxide, Carbon], Polymer [Polyethylene, Polyester], Natural [Hyaluronic Acid, Collagen, Gelatin]), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2030" is projected to grow from USD 15.21  billion in 2025 and to reach USD 21.59 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period.

Browse 908 market data Tables and 50 Figures spread through 663 Pages and in-depth TOC on "Europe Biomaterials Market by Type (Metallic [Gold, Magnesium], Ceramic [Aluminum Oxide, Carbon], Polymer [Polyethylene, Polyester], Natural [Hyaluronic Acid, Collagen, Gelatin]), Application (Orthopedic, Dental, CVD, Ophthalmology) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-biomaterials-market-33257251.html

The Europe biomaterials market is experiencing growth, driven by the strong public healthcare systems, well-established medical device manufacturing base, and increasing incidence of chronic conditions in the region.

The stainless steel segment accounted for the largest share in the metallic biomaterials type segment of the Europe biomaterials market in 2024.

Based on type, the metallic biomaterials market is segmented into metallic (stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, silver, magnesium, and other metallic biomaterials). The stainless steel sub-segment accounted for the largest share in the metallic biomaterial segment. The large market size for this sub-segment is primarily attributed to the extensive use of stainless steel in medical devices, such as orthopedic implants, trauma fixation devices, cardiovascular instruments, and surgical instruments. Stainless steel provides an optimal combination of mechanical properties, anti-corrosion properties, and costs. The aging population is also fueling the demand for stainless steel-based devices, as the senior population requires more orthopedic, cardiovascular, dental, and neurological procedures.  

By ceramic biomaterials type, the calcium phosphate segment is expected to register the highest growth in the Europe biomaterials market.

The Europe biomaterials market is segmented by type into calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon, and glass. The calcium phosphate is projected to be the fastest-growing segment in ceramic biomaterials. This high growth is attributed to its highest similarity to natural bone, promoting biocompatibility and bone bonding. Calcium phosphate biomaterials are used in orthopedic and dental applications such as bone graft substitutes, orthopedic and dental implant coatings, and bone fillers. The increased number of orthopedic and dental surgical procedures and increased demand for bone regeneration and repair are favoring the increased adoption of this biomaterial. In addition to this, the increased ability to resorb or integrate at a constant rate within the body makes this biomaterial most suitable for contemporary treatments that are oriented towards healing.

Germany accounted for the largest share of the Europe biomaterials market in 2024.

The Europe biomaterials market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe, with   Germany being the largest market in the region. Germany's extensive network of medical-device manufacturers, biopharma companies, university hospitals, and specialized orthopedic and cardiac centers fuels the market growth. The country's leadership reflects strong R&D funding for regenerative medicine, rapidly growing demand for orthopedic, cardiovascular, and dental implants in an aging population, and early adoption of advanced materials such as bioresorbable polymers, magnesium-based implants, and 3D-printed devices.

Key players in the Europe biomaterials market include BASF SE (Germany), Covestro AG (Germany), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex PLC (UK), CeramTec GmbH (Germany), and GELITA AG (Germany).

Don’t miss out on business opportunities in Europe Biomaterials Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/